Novavax COVID-19 Vaccine Proves to be Highly Effective in Late-Stage Trial

Veuer 2021-06-14

Views 83

The American biotechnology company Novavax is set to offer the US a fourth COVID-19 vaccine. Veuer’s Maria Mercedes Galuppo has the story.

Share This Video


Download

  
Report form